VIVIMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations & Disclosure Requirements), 2015, further to our letter dated 26.12.2024, we hereby bring to your notice that the meeting of the Board of Directors of the Company is scheduled to be held on 14th day of February, 2025 at Hyderabad inter alia to consider and approve, un-audited Financial Results (Standalone & Consolidated) of the company for the Quarter and nine months ended December 31, 2024. Further, we would like to inform that pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the company has intimated its 'Designated Persons including Directors' regarding the closure of trading window from 01.01.2025 to till 48 hours after the declaration of un-audited Financial Results (Standalone & Consolidated) of the company for the Quarter and nine months ended December 31, 2024.